Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats
- 1 May 1995
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 56 (25) , PL443-PL447
- https://doi.org/10.1016/0024-3205(95)00218-u
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatmentBrain Research, 1991
- A prospective study of tardive dyskinesia in JapanArchiv Fur Psychiatrie Und Nervenkrankheiten, 1991
- Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesiaPsychopharmacology, 1990
- Striatal dopamine D2 receptors in tardive dyskinesia: PET study.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitationBiochemical Pharmacology, 1984
- Increased Brain Dopamine and Dopamine Receptors in SchizophreniaArchives of General Psychiatry, 1982
- Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitorsPsychopharmacology, 1982
- Tardive dyskinesia: A clinical test of the supersensitivity hypothesisPsychopharmacology, 1979
- Multiple receptors for dopamineNature, 1979